Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral Arteries

PHASE3CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Carotid, Aortic, Renal or Peripheral Artery Disease

Interventions

DRUG

Gadobenate Dimeglumine

0.1 mmol/kg, single dose

DRUG

Gadopentetate Dimeglumine

Double dose of 0.2 mmol/kg

Trial Locations (1)

Radiology Department Zhongshan Hospital, Fudan University, Shanghai